Raymond James & Associates’s Inari Medical, Inc. Common Stock NARI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $609K | Buy |
14,771
+8,114
| +122% | +$335K | ﹤0.01% | 2981 |
|
|
2024
Q2 | $321K | Buy |
6,657
+96
| +1% | +$4.62K | ﹤0.01% | 3312 |
|
|
2024
Q1 | $315K | Buy |
6,561
+3,228
| +97% | +$155K | ﹤0.01% | 3324 |
|
|
2023
Q4 | $216K | Buy |
+3,333
| New | +$216K | ﹤0.01% | 3448 |
|
|
2023
Q1 | – | Sell |
-3,752
| Closed | -$238K | – | 3939 |
|
|
2022
Q4 | $238K | Sell |
3,752
-583
| -13% | -$37.1K | ﹤0.01% | 3324 |
|
|
2022
Q3 | $315K | Sell |
4,335
-83
| -2% | -$6.03K | ﹤0.01% | 3131 |
|
|
2022
Q2 | $300K | Buy |
4,418
+32
| +0.7% | +$2.17K | ﹤0.01% | 3224 |
|
|
2022
Q1 | $398K | Buy |
4,386
+76
| +2% | +$6.9K | ﹤0.01% | 3192 |
|
|
2021
Q4 | $393K | Sell |
4,310
-3,956
| -48% | -$361K | ﹤0.01% | 3253 |
|
|
2021
Q3 | $670K | Sell |
8,266
-10,056
| -55% | -$815K | ﹤0.01% | 2844 |
|
|
2021
Q2 | $1.71M | Sell |
18,322
-1,715
| -9% | -$160K | ﹤0.01% | 2209 |
|
|
2021
Q1 | $2.14M | Buy |
20,037
+11,587
| +137% | +$1.24M | ﹤0.01% | 1959 |
|
|
2020
Q4 | $738K | Buy |
+8,450
| New | +$738K | ﹤0.01% | 2529 |
|